Danazol for the treatment of idiopathic thrombocytopenic purpura.
Acta Haematol
; 74(2): 97-8, 1985.
Article
em En
| MEDLINE
| ID: mdl-3937423
ABSTRACT
Fourteen patients with idiopathic thrombocytopenic purpura (ITP) refractory to steroids and/or splenectomy were treated with danazol (200 mg 3 times a day) for 2 months. The following responses were achieved excellent (platelet count greater than 100 X 10(9)/l) in 5 patients; good (greater than 50 X 10(9)/l, but less than 100 X 10(9)/l) in 2 patients, and poor in (no increase of platelet count) 7 patients. In three cases remission lasted more than 7 months. Danazol was well tolerated and in most patients better suited than steroids for long-term intake.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Pregnadienos
/
Púrpura Trombocitopênica
/
Danazol
Idioma:
En
Ano de publicação:
1985
Tipo de documento:
Article